Grand Island, USA

Fresenius Kabi USA develops, manufactures and markets injectable pharmaceuticals, with important products in the oncology, anti-infective, anaesthetic / analgesic and critical care fields. Fresenius Kabi USA operates out of three sites, located in upstate New York, North Carolina and Illinois.

The Grand Island facility is located just a few minutes from the spectacular Niagara Falls, near Buffalo, NY. The site employs approximately 900 people in three buildings. A two-building site expansion is underway with leading industry isolator filling technology and additional lyophilizers.

Technologies:

• Lyophilization
• Aseptic liquid filling
• Terminal sterilization

Products:

• Oncologics
• Anti-infectives
• Anaesthetics
• Analgesics
• Critical care
• Schedule II & IV Controlled Drugs

Containers:

• Plastic vials (3 - 200 ml)
• Glass vials (2 - 200 ml)

Certificates:

• US-FDA
• Canada-Health Canada
• DEA

Markets:

• USA